Veterinary Medicine
Veterinary Medicine integrates clinical veterinary care, zoonotic disease surveillance, antimicrobial stewardship, and translational research to maintain animal and human force health. Capabilities include point-of-care diagnostics, field surgical support, vaccine development, biosurveillance, and telemedicine to reduce transmission, preserve operational readiness, and support prolonged field care.
Technical Challenges
Zoonotic disease detection and rapid differentiation from human pathogens in field settings
Antimicrobial resistance (AMR) and stewardship in operational veterinary medicine
Delivering surgical and critical care to animals in austere, prolonged-field-care environments
Limited validated point-of-care diagnostics optimized for diverse species and environmental extremes
Emerging Opportunities
Rugged, multi-species point-of-care diagnostic platforms for rapid pathogen ID and AMR profiling
Field-deployable vaccines and thermostable biologics for priority zoonoses
Validated telehealth workflows and decision-support tools for veterinary care in distributed operations
Standardized protocols and training for integrated human-animal biosurveillance in theater
Current and Emerging Technologies in Veterinary Medicine
Point-of-Care & Field Diagnostics
Portable PCR, isothermal amplification, lateral-flow immunoassays, and CRISPR-based sensors adapted for multi-species samples enable rapid zoonotic pathogen detection and antimicrobial resistance markers at the point of need.
Telemedicine & Remote Monitoring
Secure telehealth platforms, wearable physiologic sensors for animals, and asynchronous image/vid consultation support prolonged and distributed care, force veterinary reachback, and remote triage.
Vaccines, Therapeutics & AMR Strategies
Next-generation vaccines (thermostable, vector and mRNA platforms), monoclonal therapeutics, and optimized antimicrobial stewardship protocols reduce zoonotic risk and combat resistant infections in operational settings.
Regenerative & Surgical Technologies
Field-adapted surgical tools, hemostatic agents, biologic scaffolds, and regenerative approaches address traumatic wounds and polytrauma in canines and other service animals used in operational roles.
Biosurveillance & One Health Analytics
Integrated biosurveillance platforms combining animal health data, genomic sequencing, and environmental sensors support early warning for outbreaks and inform force health protection strategies using One Health principles.
Importance to Military Medicine
Force Health Protection
Veterinary care prevents zoonotic transmission, protects working animals, and reduces infection risk to personnel, directly preserving mission capability.
Prolonged & Austere Care Support
Capabilities for field surgery, diagnostics, and telehealth extend clinical reach in delayed-evacuation or remote operations for animal casualties and human-animal co-morbidities.
Operational Readiness & Training
Maintaining veterinary assets, preventive medicine, and rapid outbreak response preserves unit readiness and supports force projection.
Biosurveillance and Force Protection
Animal health data provide sentinel indicators for emerging biological threats, enhancing early detection and mitigation for both military and civilian populations.
Alignment with the MTEC Mission
Supports MTEC’s DoD-focused mission by accelerating field-ready biomedical tools that improve force health and operational survivability.
Enables translational research and public–private collaboration to move veterinary diagnostics, vaccines, and therapeutics into practice faster.
Advances prolonged and distributed care solutions—telemedicine, rugged diagnostics, and decision support—aligned with MTEC priorities.
Fosters One Health approaches that integrate animal and human biosurveillance to enhance national biodefense and readiness.
Dual-Use (Military + Civilian) Applications
Dual-use diagnostics developed for military veterinary use translate to civilian public health labs for zoonotic outbreak response and rural veterinary clinics.
Thermostable vaccines and biologics reduce cold-chain dependence for humanitarian and civilian animal health programs.
Telemedicine platforms and remote monitoring approaches improve access to specialty vet care in underserved civilian and disaster-response settings.
One Health biosurveillance tools inform public health interventions, agricultural biosecurity, and biodefense across military and civilian sectors.
Explore MTEC Members with Veterinary Medicine Capabilities
MTEC members bring multidisciplinary strengths—veterinary clinicians, translational researchers, diagnostics developers, and industry manufacturing partners—to accelerate prototype to field validation.
Explore member profiles to identify partners with experience in point-of-care assay development, thermostable biologics, telehealth integration, and operational veterinary medicine for collaboration opportunities.
41 Members with Veterinary Medicine capabilities.
The University of Texas System is a leading public university system in the United States, dedicated to improving lives through education, health care, and research. With over 256,000 students enrolled across 14 institutions, the UT System is committed to providing affordable access to higher education and producing a skilled workforce to drive Texas's economy.
SIMETRI is a woman-and-minority owned small business based in Winter Park, Florida, specializing in modeling, simulation, and training technologies. Founded in 2009, the company focuses on delivering innovative products and services that enhance the human experience and improve client outcomes through advanced training and program management analysis.
FiteBac Technology/FiteBac Pharma's K21 uniquely targets the underlying disease state, given that most diseases involve microbial-associated inflammation and mitochondrial dysfunction. FiteBac Technology innovations stem from the work of numerous international academic research scientists. FiteBac Pharma K21 is the blockbuster antimicrobial small molecule designed to modulate biological, immunological, and metabolic systems for treating a wide range of infectious and inflammatory diseases. This patented drug substance has demonstrated the ability to safely eliminate bacterial, fungal, and viral infections, enhance innate immunity, induce mitophagy while improving mitochondrial and cellular metabolism, accelerate wound healing, and even promote the development of zebrafish and chickens, leading to increased adult mass. Rigorous research from Dr. Bhupesh Prusty's laboratory and Dr Christopher Rongo's laboratory is focused on various aspects of mitochondrial remodeling and reprograming, as well as mitochondrial-to-nuclear signaling with K21.
STAT Therapeutics is focused on developing a drug- device combination for easy, rapid administration of intramuscular, life-saving medications by users in any setting, aiming to improve access and usability for acute emergency treatments such as pain, anaphylaxis, and seizures.
Seek Labs is a biotechnology company headquartered in Salt Lake City, Utah, dedicated to advancing scientific discovery and delivering universal healthcare solutions. The company specializes in next-generation point-of-care molecular diagnostics and programmable CRISPR-based therapeutics, aiming to bridge the gap between disease outbreak and intervention. Powered by its proprietary AI discovery engine, BioSeeker™, Seek Labs is building a modular, full-stack system that enables rapid response to emerging pathogens, scalable precision treatments, and accessible diagnostics. The company is committed to global health innovation, sustainability, and community engagement, and is a proud member of Utah's BioHive life sciences ecosystem. Seek Labs' mission is to empower individuals with healthcare solutions tailored to their specific needs, revolutionizing the detection and treatment of diseases for both human and animal health.
Zeteo Tech is a venture-backed biodefense and medical device company that has developed a revolutionary new class of fieldable biological mass spectrometers. Their technology identifies airborne microbes, proteins, and lipids, enabling rapid screening for infectious diseases and bio-threats. With a focus on cost-effective solutions, Zeteo Tech aims to enhance biodefense capabilities and improve patient screening for diseases like tuberculosis.
The University of Cincinnati Office of Research is a premier R1 urban research institution dedicated to advancing transformative knowledge and disruptive discoveries that address real-world challenges. Guided by its Research2030 strategic plan, the Office fosters interdisciplinary collaboration, supports innovative research initiatives, and connects industry, government, and community partners with UC's thought leaders. The Office accelerates economic growth and societal impact by investing in key research strengths such as analytics, cyber, robotics, sensors, skin science, adolescence, cancer, digital humanities, infectious diseases, medical devices, neuroscience, smart cities, sustainability, urban futures, and water. With a strong commitment to transparency, compliance, and research security, the Office provides comprehensive support for faculty, students, and staff throughout the research lifecycle, ensuring excellence and integrity in all scholarly activities. Specialized programs and support offices include biosafety, animal care, research integrity, cybersecurity, human research protection, defense research initiatives, government cost compliance, and radiation safety, all designed to uphold the highest standards of ethical, safe, and innovative research. The Office also keeps the community informed and engaged through its monthly 'Findings' newsletter, highlighting impactful research, partnerships, and opportunities.
Limax Biosciences is dedicated to revolutionizing tissue healing through innovative biomaterials inspired by the natural slime of slugs. Their hydrogels provide superior adhesion and healing capabilities, addressing unmet medical needs both inside and outside the body.
Matinicus Pharma is a life sciences company focused on developing stabilized, ultra-pure bovine hemoglobin solutions for addressing local and systemic oxygen deprivation. The company applies proprietary manufacturing techniques to produce universally compatible, room-temperature stable hemoglobin-based oxygen carriers suitable for clinical emergency, organ transplantation, and veterinary applications. Founded by experts in biologics purification and clinical development, it targets unmet medical needs in human and animal health by providing alternatives to traditional blood transfusion and enhancing organ preservation.
The University of Maryland, Baltimore (UMB) is Maryland’s public health, law, and human services university. It is dedicated to improving the human condition and serving the public good through education, research, clinical care, and service. UMB is the founding campus of the University System of Maryland and offers a wide range of professional degrees in health care, human services, and law.
Cresilon is a Brooklyn-based biotech company dedicated to saving lives through innovative hemostatic solutions. Their mission is to provide safe, effective, and reliable products that stop bleeding quickly, utilizing plant-based technology to revolutionize wound care in both veterinary and human medicine.
Bench in a Box Technologies develops point-of-care diagnostic platforms tailored for field and low-resource environments. The company's core technology, Protein Signal Amplification (PSA), allows rapid, electricity-free molecular detection at room temperature, delivering results in five minutes or less, without the need for refrigeration or specialized laboratory infrastructure. Drawing on extensive expertise in molecular diagnostics, drug development, and logistics, the company aims to make high-quality diagnostics broadly accessible.
Aspen Medical is a global leader in innovative healthcare solutions, specializing in delivering high-quality healthcare services in remote, challenging, and under-resourced environments. Established in 2003 in Australia, the company operates across Australia, the UK and Europe, the Middle East, North America, Africa, Asia, and the Indo-Pacific region. Aspen Medical is the only commercial organization in the world certified by the World Health Organization as an Emergency Medical Team for infectious disease outbreaks and trauma surgical operations. The company is committed to social responsibility, diversity, and inclusion, and is a certified B Corp and a signatory to the United Nations Global Compact. Aspen Medical partners with governments, NGOs, and private sector clients to provide end-to-end healthcare solutions, including hospitals and clinics, health advisory services, humanitarian and disaster response, aeromedical retrievals, occupational health, training, health technology, aged care, and medical equipment supply. The Aspen Medical Foundation, the company's registered charity, supports scholarships, community partnerships, and philanthropic initiatives, with a focus on empowering healthcare workers and communities.
Combat SNS (Combat Medical Consulting, CMC) is a Service-Disabled Veteran-Owned Small Business (SDVOSB) dedicated to bridging the gap between innovative medical technologies and operational end users in the Department of Defense (DoD), Department of Veterans Affairs (VA), and other government agencies. With over 30 years of expertise in direct sales, government procurement, and market integration, CMC specializes in high-quality medical supply distribution, consulting, and product development. Their mission is to accelerate the adoption of advanced medical solutions, ensuring best-value procurement and broad impact across public health and defense sectors. CMC is recognized for its comprehensive approach, from market research and product validation to training, certification, and field deployment.
Phycin, Inc. is a pioneering biotechnology company that harnesses the power of algae to produce high-quality, endotoxin-free growth factors for various applications, including eye care, cell culture, and clean meat production. With a focus on safety, efficiency, and cost-effectiveness, Phycin is revolutionizing the growth factor market through innovative technologies developed over a decade of research.
The University of Minnesota's Research and Innovation Office (RIO) serves as a central resource for conducting, managing, and sponsoring research. It aims to facilitate collaborative research that addresses complex problems and promotes innovations that improve lives. RIO oversees research compliance and administration, fostering a culture of integrity and ethical practices in research. Additionally, RIO is committed to enhancing research capacity through various funding opportunities and strategic initiatives, including the management of specialized facilities for biocontainment research.

Safi Biotherapeutics
Next-Generation Manufactured Red Blood Cells for Extended Battlefield Blood Supply: Safi Biotherapeutics
Safi Biotherapeutics is developing manufactured red blood cells (mRBCs) with extended shelf life to improve battlefield transfusion readiness and emergency trauma care.
Non-Invasive Glymphatic (GF) Monitoring and Recovery Optimization for Warfighter Cognitive Readiness
Applied Cognition is developing non-invasive glymphatic monitoring and recovery technologies to enhance warfighter cognitive readiness, resilience, and sleep recovery.
Moberg Analytics
Moberg Analytics – Advanced Brain Monitoring & Critical Care Informatic
Moberg’s platform unifies brain monitoring data for faster, precise treatment of severe brain injuries in military and civilian care.
University of California San Francisco
TemPredict: AI-Driven Wearable Monitoring for Early Illness Detection and Warfighter Readiness
TemPredict: AI wearables detect early illness and health risks to support warfighter readiness.